(Halifax, NS) Researchers across Nova Scotia are launching a project aimed at detecting the presence of the virus that causes COVID-19 in human wastewater, helping to identify the potential presence of the virus quickly and before it can spread. Building on the recent results of a pilot study, the research team has begun to collect… Read More
Like many companies, when we launched our strategic plan in January, we had no idea what the year would hold. We will remember 2020 not only as a year of unprecedented challenges, but of resilience and innovation. In this post, we’ll cover some of the milestones that made this a truly monumental year for LuminUltra…. Read More
Vancouver, B.C. – Dec. 14, 2020 – Biotechnology leader LuminUltra has partnered with BuiltSpace, a building data and asset tracking specialist, and scientists at the University of British Columbia (UBC) to test the effectiveness of disinfection efforts in educational settings for early detection of SARS-CoV-2, the virus that causes COVID-19. “The battle against COVID-19 requires… Read More
LuminUltra’s point-of-need and high-volume testing solutions capable of serving a range of COVID testing needs in under two hours FREDERICTON, NB, December 3, 2020 – Biotechnology front-runner LuminUltra is pleased to announce that it has received Health Canada authorization to sell and distribute its GeneCount® COVID-19 RT-qPCR Assay Kit. This authorization allows LuminUltra, the Canadian… Read More
FREDERICTON, NB, November 30, 2020 – Biotechnology front-runner LuminUltra today announced the acquisition of Source Molecular Corporation, a leader in lab-based testing solutions for microbial source tracking of pathogens including SARS-CoV-2, the virus that causes COVID-19. With this acquisition, LuminUltra has further expanded its range of molecular testing options for a variety of uses cases…. Read More
Partnership brings together leaders in their respective fields to advocate for an innovative, science-based approach to pandemic management CANADA – Nov. 18, 2020 – Biotechnology leader LuminUltra has partnered with The Infection Prevention Strategy (TIPS) in the fight against COVID-19 to provide global education on the importance of verifying proper disinfection protocols with science-based methodology. As a global leader in molecular diagnostic testing, LuminUltra has developed portable qPCR technology that can test for the presence of SARS-CoV-2 –… Read More
A Research Collaboration Between LuminUltra, Dalhousie University and Halifax Water Demonstrates Wastewater Data Is a Powerful Tool in Early Detection and Tracking COVID-19 Prevalence within Communities FREDERICTON, NB, October 21, 2020 – LuminUltra, a Canada-based biotechnology leader and portfolio company of XPV Water Partners, recently filed a patent for the first complete, rapid, and on-site… Read More
Over the course of the COVID-19 pandemic, it is likely that many people have forgotten about Legionella, which has been described as a “quiet pandemic” by legislators in the United States. While the focus of many government health authorities has been to react to and reduce the impact of COVID-19, the many stay at home… Read More
The phrase “back-to-school” brings to mind fresh notebooks, new teachers, and friends. This fall, in the midst of the COVID-19 pandemic, it’s filled with uncertainty and anxiety. Teachers are concerned about returning to the classroom, with 2 out of 3 preferring the idea of teaching online. Students are thinking less about the clubs they’ll join… Read More
LuminUltra Technologies Ltd. is proud to announce that we’ve submitted our GeneCount® COVID-19 RT-qPCR Assay Kit to the U.S. Food and Drug Administration for Emergency Use Authorization and Health Canada for an Interim Order. With this authorization we’ll be able to provide testing facilities throughout North America with a complete, customizable clinical COVID-19 testing solution…. Read More
Update your browser to view this website correctly. Update my browser now
